GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity

被引:0
|
作者
Stumpf, M. [1 ]
Dar, S. A. [1 ]
Rao, S. [1 ]
Doyle, A. [1 ]
机构
[1] Univ Virginia, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A-62
引用
收藏
页码:999 / 999
页数:1
相关论文
共 50 条
  • [1] Use of SGLT2i in Non-Diabetic Kidney Transplant Recipients
    Quilis, Aina
    Gavela, Eva
    Kanter, Julia
    Castro-Alonso, Cristina
    Calatayud, Emma
    Vivo, Elena
    Parra, Manuel
    Gandia, Paula
    Sancho, Asuncion
    TRANSPLANTATION PROCEEDINGS, 2025, 57 (01) : 24 - 26
  • [2] Initiation of SGLT2i Versus GLP1-RA and the Risk of Chronic Kidney Disease in Persons with Type 2 Diabetes Mellitus
    Jensen, Simon K.
    Heide-Jorgensen, Uffe
    Andersen, Ina T.
    Thomsen, Reimar W. W.
    Christiansen, Christian Fynbo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 87 - 87
  • [3] Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry?
    Gallo, M.
    Monami, M.
    Ragni, A.
    Renzelli, V.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [4] Initiation of SGLT2i vs. GLP1-RA and the Risk of Acute Kidney Injury in Persons with Type 2 Diabetes Mellitus
    Heide-Jorgensen, Uffe
    Jensen, Simon K.
    Andersen, Ina T.
    Thomsen, Reimar W. W.
    Christiansen, Christian Fynbo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 362 - 363
  • [5] Combining SGLT2is, GLP1-RAs and nsMRAs in Diabetes: A Scoping Review of Current and Future Perspectives
    Stougaard, Elisabeth Buur
    Curovic, Viktor Rotbain
    Hansen, Tine Willum
    DIABETES THERAPY, 2025, : 799 - 811
  • [6] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I197 - I198
  • [7] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [8] Are Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) Safe to Use in Kidney Transplant Recipients with Diabetes?
    Angjeli, A.
    Montada-Atin, T.
    Nisenbaum, R.
    Dacouris, N.
    Nash, M.
    Zaltzman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S564 - S564
  • [9] GLP-1 receptor agonists and SGLT-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
    Zheng, K.
    Azhie, A.
    You, X.
    Naghibzadeh, M.
    Tan, E.
    Naimimohasses, S.
    Sridhar, V.
    Gupta, S.
    Chen, S.
    Dash, S.
    Jaeckel, E.
    Woo, M.
    Singh, S.
    Cherney, D.
    Bhat, M.
    LIVER TRANSPLANTATION, 2024, 30 : 42 - 42
  • [10] SGLT2i: new perspectives in diabetes and kidney disease
    Ferrannini, Giulia
    Cosentino, Francesco
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E4 - E4